Cytokinetics (CYTK) Total Debt (2016 - 2025)
Historic Total Debt for Cytokinetics (CYTK) over the last 13 years, with Q3 2024 value amounting to $105.5 million.
- Cytokinetics' Total Debt rose 7330.54% to $105.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $105.5 million, marking a year-over-year increase of 7330.54%. This contributed to the annual value of $68.5 million for FY2023, which is 570.65% up from last year.
- Latest data reveals that Cytokinetics reported Total Debt of $105.5 million as of Q3 2024, which was up 7330.54% from $106.0 million recorded in Q2 2024.
- In the past 5 years, Cytokinetics' Total Debt registered a high of $106.0 million during Q2 2024, and its lowest value of $45.3 million during Q1 2020.
- In the last 5 years, Cytokinetics' Total Debt had a median value of $61.2 million in 2022 and averaged $61.0 million.
- In the last 5 years, Cytokinetics' Total Debt tumbled by 418.45% in 2023 and then soared by 7330.54% in 2024.
- Cytokinetics' Total Debt (Quarter) stood at $46.2 million in 2020, then grew by 2.51% to $47.4 million in 2021, then skyrocketed by 36.74% to $64.8 million in 2022, then grew by 5.71% to $68.5 million in 2023, then soared by 54.12% to $105.5 million in 2024.
- Its Total Debt stands at $105.5 million for Q3 2024, versus $106.0 million for Q2 2024 and $68.3 million for Q1 2024.